The molecular mechanisms inducing YAP1 activation by CT are not yet known, and we speculate that stromal populations present in the tumor, such as inflammatory cells, may induce upstream regulators of this signature (i.e., TGFβ signaling) thus leading to the acquisition of PQL traits before CT treatment. The gene discussed is YAP1; the disease is neoplasm.